Debby Ngo, MD in Boston, MA - Medicare Internal Medicine

Debby Ngo, MD is a medicare enrolled "Internal Medicine - Critical Care Medicine" physician in Boston, Massachusetts. Her current practice location is 330 Brookline Ave, Boston, Massachusetts. You can reach out to her office (for appointments etc.) via phone at (617) 667-5864.

Debby Ngo is licensed to practice in Massachusetts (license number 244877) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1295981009.

Contact Information

	Debby Ngo, MD
	330 Brookline Ave, Boston, MA 02215-5400
	(617) 667-5864
	(617) 667-4849

Physician's Profile

Full Name	Debby Ngo
Gender	Female
Speciality	Internal Medicine - Critical Care Medicine
Location	330 Brookline Ave, Boston, Massachusetts
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1295981009
Provider Enumeration Date: 08/12/2008
Last Update Date: 10/04/2016

Medicare PECOS Information:

PECOS PAC ID: 5294994828
Enrollment ID: I20120806000145

Medical Identifiers

Medical identifiers for Debby Ngo such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1295981009	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RP1001X	Internal Medicine - Pulmonary Disease	244877 (Massachusetts)	Secondary
207RC0200X	Internal Medicine - Critical Care Medicine	244877 (Massachusetts)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Debby Ngo allows following entities to bill medicare on her behalf.

Entity Name	Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1194765438 PECOS PAC ID: 4486567104 Enrollment ID: O20031204000918

News Archive

Engineered nanosponges can reduce severity of infections caused by group A Streptococcus

In a new study, researchers show that engineered nanosponges that are encapsulated in the membranes of red blood cells can reduce the severity of infections caused by group A Streptococcus, the bacteria responsible for strep throat and life-threatening infections such as necrotizing fasciitis, or flesh-eating disease.

State-level debate about Medicaid expansion heats up

ov. Jay Nixon led a three-front charge Tuesday to expand Missouri's Medicaid program, meeting privately with reluctant state senators, rallying publicly with hundreds of disability advocates and chatting with the nation's top health care official about whether particular Medicaid proposals could win federal approval.

Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

Vanda Pharmaceuticals Inc. today announced its plans to initiate a Phase IIb/III clinical trial of tasimelteon in patients with Major Depressive Disorder (MDD). The trial is expected to begin during the second half of 2011. Tasimelteon is currently being evaluated in Phase III clinical trials for the treatment of Non-24-Hour Sleep/Wake Disorder (N24HSWD) in blind individuals without light perception.

Study confirms that success of sunless tanning products depends on young women

Sunless tanning - whether with lotions, bronzers or tanning pills - has been promoted as an effective substitute to dodge the health risks of ultraviolet rays, but if the products don't provide the perfect tan, young women likely will not use them, according to a Baylor University researcher.

Signaling protein has key role in fighting bacterial infection and inflammation in intestinal tract: Study

A signaling protein that is key in orchestrating the body's overall immune response has an important localized role in fighting bacterial infection and inflammation in the intestinal tract, according to a study by UC San Diego School of Medicine investigators, published in the journal Cell Host and Microbe.

Entity Name	Beth Israel Deaconess Medical Center Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1548202641 PECOS PAC ID: 8123936119 Enrollment ID: O20041001000827

Engineered nanosponges can reduce severity of infections caused by group A Streptococcus

State-level debate about Medicaid expansion heats up

Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

Study confirms that success of sunless tanning products depends on young women

Signaling protein has key role in fighting bacterial infection and inflammation in intestinal tract: Study

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Debby Ngo is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Debby Ngo, MD 330 Brookline Ave, Boston, MA 02215-5400 Ph: (617) 667-5864	Debby Ngo, MD 330 Brookline Ave, Boston, MA 02215-5400 Ph: (617) 667-5864

News Archive

Engineered nanosponges can reduce severity of infections caused by group A Streptococcus

State-level debate about Medicaid expansion heats up

Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

Study confirms that success of sunless tanning products depends on young women

Signaling protein has key role in fighting bacterial infection and inflammation in intestinal tract: Study

Internal Medicine Doctors in Boston, MA

Kaitlyn My-tu Lam, MBBS Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-724-7738
Kui Toh Gerard Leong, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit Street, Massachusetts General Hospital, Boston, MA 02114 Phone: 617-726-8862
Ruma Rajbhandari, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-525-6841
Alaka Ray, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2066
Meghan E Sise, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2862
Aaron Dickstein, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Box 233, Boston, MA 02111 Phone: 617-636-5883 Fax: 617-636-9292
Dr. Felicia Elizabeth Patch, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Massachusetts Ave, Crosstown 2, Boston, MA 02118 Phone: 617-414-4376 Fax: 617-414-4676

Debby Ngo, MD - Medicare Internal Medicine in Boston, MA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Engineered nanosponges can reduce severity of infections caused by group A Streptococcus

State-level debate about Medicaid expansion heats up

Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

Study confirms that success of sunless tanning products depends on young women

Signaling protein has key role in fighting bacterial infection and inflammation in intestinal tract: Study

Engineered nanosponges can reduce severity of infections caused by group A Streptococcus

State-level debate about Medicaid expansion heats up

Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

Study confirms that success of sunless tanning products depends on young women

Signaling protein has key role in fighting bacterial infection and inflammation in intestinal tract: Study

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Engineered nanosponges can reduce severity of infections caused by group A Streptococcus

State-level debate about Medicaid expansion heats up

Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

Study confirms that success of sunless tanning products depends on young women

Signaling protein has key role in fighting bacterial infection and inflammation in intestinal tract: Study

Internal Medicine Doctors in Boston, MA